Patent · US Active

Methods and nucleic acids for determining the prognosis of a cancer subject

US12110558B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

New Day Diagnostics, LLC · US

Inventors

Jörn LEWIN · Berlin, DE
Manuel Krispin · Berlin, DE

Key dates

Filing date	Jan 18, 2022
Grant date	Oct 8, 2024
Priority date	—
Expiry date	Jan 18, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/154
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides methods, nucleic acids and kits for determining the prognosis of a subject having cancer. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of said disorder, thereby enabling the improved diagnosis and treatment of patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.